Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-18ARDX144LAURA WILLIAMS plan to sell securities of ARDELYX, INC. under Form 144MEDIUM
LAURA WILLIAMS filed Form 144 to notify SEC of plan to sell 81898 units of ARDELYX, INC. securities around 2026-06-18, with aggregate market value of $478,284.32. The total outstanding units is 247029387.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in past 3 months i...
Small CapBiotechnology
2026-06-18BLTE144Dr. Hendrick P. Scholl plan to sell securities of Belite Bio, Inc. under Form 144MEDIUM
Dr. Hendrick P. Scholl filed Form 144 to notify SEC of plan to sell 10000 units of Belite Bio, Inc. securities around 2026-06-18, with aggregate market value of $1,483,400.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in pas...
Mid CapBiotechnology
2026-06-18IRON144RAHUL KHARA plan to sell securities of DISC MEDICINE INC under Form 144MEDIUM
RAHUL KHARA filed Form 144 to notify SEC of plan to sell 7500 units of DISC MEDICINE INC securities around 2026-06-18, with aggregate market value of $526,575.00. The total outstanding units is 38199089.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Mid CapBiotechnology
2026-06-18IRON144JOHN QUISEL plan to sell securities of DISC MEDICINE INC under Form 144MEDIUM
JOHN QUISEL filed Form 144 to notify SEC of plan to sell 34000 units of DISC MEDICINE INC securities around 2026-06-18, with aggregate market value of $2,387,140.00. The total outstanding units is 38199089.0. The amount planned to be sold represents 0.09% of total outstanding units; ...
Mid CapBiotechnology